{"id":"W945635311","doi":"10.1182/blood.v122.21.4382.4382","title":"Three-Year Follow-Up Data and Characterization Of Long-Term Remissions From An Ongoing Phase 2 Study Of Brentuximab Vedotin In Patients With Relapsed Or Refractory Hodgkin Lymphoma","year":2013,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Population; Oncology; Refractory (planetary science); Chemotherapy regimen; Phases of clinical research; CD30; Lymphoma; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001843137,0.0003240473,0.0007417738,0.0004238237,0.0004812546,0.0006147701,0.0003356203,0.0004573017,0.001253083],"category_scores_gemma":[0.001591758,0.000178298,0.0005764043,0.0003854631,0.0002723763,0.0004135544,0.0004183309,0.0007319549,0.0003007459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004239377,"about_ca_system_score_gemma":0.000337901,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007759816,"about_ca_topic_score_gemma":0.0007187082,"domain_scores_codex":[0.999397,0.0001836791,0.00008469888,0.0001381387,0.0001051275,0.0000913974],"domain_scores_gemma":[0.9986271,0.0003293658,0.0004068022,0.0001209847,0.0001676027,0.0003482208],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.0829843,0.005268802,0.7733258,0.0003571912,0.001139906,0.001994573,0.0007766386,0.002007809,0.02959364,0.0001349049,0.001933359,0.100483],"study_design_scores_gemma":[0.007273373,0.06463853,0.9147772,0.00005029956,0.0009090026,0.002117484,0.0002013616,0.001155498,0.004469824,0.0001366525,0.004238881,0.00003185256],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9969147,0.0009420158,0.0002967409,0.00004227486,0.000009366999,0.0002233222,0.0008784343,0.0000125205,0.0006805336],"genre_scores_gemma":[0.9959329,0.0002266502,0.0001969554,0.0001102098,0.00001881958,0.0001875162,0.002827423,0.00000396258,0.0004955143],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001843137,"threshold_uncertainty_score":0.009747565,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02348420202098775,"score_gpt":0.2785720876207253,"score_spread":0.2550878855997376,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}